You are here

Retrophin

Retrophin Sinks as Drug “Pharma Bro” Martin Shkreli Co-Invented Fails

Retrophin Sinks as Drug “Pharma Bro” Martin Shkreli Co-Invented Fails

Xconomy

fosmetpantotenate

Flag link:

Retrophin paid Martin Shkreli 'undisclosed sum' to settle yearslong legal disputes

Retrophin paid Martin Shkreli 'undisclosed sum' to settle yearslong legal disputes

Endpoints

Flag link:

FDA Approves Retrophin’s New Formula for Cystine Kidney Stones

FDA Approves Retrophin’s New Formula for Cystine Kidney Stones

BioSpace

cystine kidney stones

Flag link:

The Week Ahead In Biotech: Pending Clinical Readouts In Focus

The Week Ahead In Biotech: Pending Clinical Readouts In Focus

Yahoo/Benzinga

Sangamo Therapeutics

Catalyst Biosciences

Reata Pharmaceuticals

Vertex Pharmaceuticals

Gilead Sciences

TRACON Pharmaceuticals

Sorrento Therapeutics

Flag link:

FDA Action Alert: Regeneron, Sanofi, Celgene

FDA Action Alert: Regeneron, Sanofi, Celgene

BioSpace

Acer Therapeutics

Dova Pharmaceuticals

Nabriva Therapeutics

Flag link:

After years of claims and accusations, fraudster Martin Shkreli settles up with Retrophin

After years of claims and accusations, fraudster Martin Shkreli settles up with Retrophin

Endpoints

Flag link:

Shkreli settles into his new prison digs in Pennsylvania with a $30M+ lawsuit against former Retrophin colleagues

Shkreli settles into his new prison digs in Pennsylvania with a $30M+ lawsuit against former Retrophin colleagues

Endpoints

Flag link:

Go or no go? Merck, Regeneron and Alexion await US expansion

Go or no go? Merck, Regeneron and Alexion await US expansion

EP Vantage

Dova Pharmaceuticals

Flag link:

Made for TV: Shkreli running his drug company from prison cell, WSJ says

Made for TV: Shkreli running his drug company from prison cell, WSJ says

Fierce Pharma

Flag link:

Deflating R&D claims, prosecutors say an impatient Martin Shkreli conducted bogus drug study in Cyprus

Deflating R&D claims, prosecutors say an impatient Martin Shkreli conducted bogus drug study in Cyprus

Endpoints

clinical trials

Flag link:

From ‘Rain Man’ to ‘Pied Piper,’ Shkreli's actions confounded Retrophin executives

From ‘Rain Man’ to ‘Pied Piper,’ Shkreli's actions confounded Retrophin executives

Fierce Pharma

Flag link:

Feds’ case spotlights Shkreli’s disastrous biotech short — which forced him to launch Retrophin

Feds’ case spotlights Shkreli’s disastrous biotech short — which forced him to launch Retrophin

Endpoints

Flag link:

Martin Shkreli’s former biotech company Retrophin is leaving Cambridge

Martin Shkreli’s former biotech company Retrophin is leaving Cambridge

Bizjournals.com

Flag link:

Martin Shkreli in court as securities fraud case moves closer to trial

Martin Shkreli in court as securities fraud case moves closer to trial

CNBC

securities fraud

Flag link:

4 Key BioPharma Movers in the Past Week

4 Key BioPharma Movers in the Past Week

24/7 Wall St

Lexicon Pharmaceuticals

Flag link:

Retrophin (With Help From Martin Shkreli) Advances Drug for Rare Kidney Disease

Retrophin (With Help From Martin Shkreli) Advances Drug for Rare Kidney Disease

TheStreet.com

focal segmental glomerulosclerosis

Flag link:

Shire PLC (ADR) May Now Seek Rare Disease Expansion With Raptor Pharmaceutical Corp.

Shire PLC (ADR) May Now Seek Rare Disease Expansion With Raptor Pharmaceutical Corp.

Bidness, ETC

Raptor Pharmaceuticals

Flag link:

Raptor Soars After Retrophin Said to Consider Bid for Drugmaker

Raptor Soars After Retrophin Said to Consider Bid for Drugmaker

Bloomberg

Raptor Pharmaceuticals

Flag link:

Facing new conspiracy charge, Martin Shkreli pleads not guilty

Facing new conspiracy charge, Martin Shkreli pleads not guilty

Marketwatch

Flag link:

Pages